These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2290841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 8. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM, Alcántara AG, Barcia D.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 Aug; 26(6):399-402. PubMed ID: 9972593
    [Abstract] [Full Text] [Related]

  • 9. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV.
    J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The obsessive-compulsive disorder. Pharmacotherapeutic and neurobiological aspects and the relation to affective pathology].
    Fornaro P.
    Minerva Psichiatr; 1988 Mar; 29(2):95-103. PubMed ID: 3057306
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacology of sertraline: a review.
    Heym J, Koe BK.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
    [Abstract] [Full Text] [Related]

  • 13. Potential antidopaminergic effects of serotonin reuptake inhibitors.
    Kim SW, Dysken MW.
    J Clin Psychiatry; 1991 Jan; 52(1):42. PubMed ID: 1988420
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report.
    Pasquini M, Garavini A, Biondi M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):157-9. PubMed ID: 15610960
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The relationship of antiobsessional and antidepressant effects of tricyclic antidepressants.
    Mavissakalian M, Turner SM, Michelson L, Jacob R.
    Psychopharmacol Bull; 1986 Jan; 22(1):161-6. PubMed ID: 3523574
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of obsessive-compulsive disorder].
    Jiang YC.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Feb; 17(1):56-8. PubMed ID: 6468115
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.